Laboratorios Sophia S.A de C.V.

13 marketed · 7 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Laboratorios Sophia S.A de C.V.

What are Laboratorios Sophia S.A de C.V.'s marketed drugs?

Top marketed products include Dorzolamide-timolol and latanoprost, Dorzolamide-timolol-brimonidine and latanoprost, Manzanilla Sophia®, Meticel Ofteno®, Meticel Ofteno® 0.5%, Optive®.

What is Laboratorios Sophia S.A de C.V.'s pipeline?

Laboratorios Sophia S.A de C.V. has 7 drugs in Phase 3, 0 in Phase 2, 3 in Phase 1. Late-stage candidates include Alleance®, Difluprednate 0.05%, Krytantek Ofteno®, Moxifloxacin / Dexamethasone Ophthalmic Solution.

Related